Charles Cherington, 10% Owner at Ernexa Therapeutics Inc. (ERNA), bought 42,482,326 shares at $0.10 ($4.2M) on 2025-06-09, disclosed to the SEC on 2025-06-11.
Open-market purchase of $4.2M ERNA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.10 | 21,241,163 | $2.1M | 50.0% |
| 2 | $0.10 | 21,241,163 | $2.1M | 50.0% |
| Total | $0.10 avg | 42,482,326 | $4.2M | 100% |
| Filing → |
| CMRA | BUY | 2023-09-11 | $2.1M | — | Filing → |
| CMRA | BUY | 2023-08-25 | $898K | — | Filing → |
| CMRA | BUY | 2023-01-06 | $1.8M | — | Filing → |